Genmab — September 2016
-
Dara i præklinik mod CLL. CONCLUSIONS:
These unique and substantial effects of daratumumab on CLL viability and dissemination support the investigation of its use in a clinical setting of CLL. http://www.ncbi.nlm.nih.gov/pubmed/27637890 -
Er man novice som jeg ud i immunterapi, er her en artikel, hvor man kan få udvidet sin horisont. http://jyllands-posten.dk/nyviden/ECE9019958/kroppens-eget-forsvar-skal-hjaelpes-til-at-kurere-kraeft/
-
-
http://www.medscape.com/viewarticle/869007 Lille interview angående alder ved immunterapi for ældre melonapatienter, hvis nogen keder sig over manglende action.
-
Det er vist lang tid siden vi har set en så sløv omsætning som i dag. Det er der forøvrigt også i mange andre af de aktier jeg holder øje med.
-
Og så lidt aktivitet på chats og på facebookgrupperne.

-
God morgen. 3 dage den store aktivitet her på chatten.Er det stilhed før stormen

-

-
Hvad sker der i denne uge:-)
-
Det ser du her: https://play.borsen.dk/social/57e50647d99b63192e1f4e63
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind